B
Bernard Witkop
Researcher at National Institutes of Health
Publications - 2
Citations - 204
Bernard Witkop is an academic researcher from National Institutes of Health. The author has contributed to research in topics: In vivo & Serotonin. The author has an hindex of 2, co-authored 2 publications receiving 201 citations.
Papers
More filters
Journal ArticleDOI
Studies with reversible inhibitors of monoamine oxidase: Harmaline and related compounds
TL;DR: Harmaline and related compounds have been shown to be potent inhibitors of monoamine oxidase effecting 50 per cent inhibition of serotonin metabolism at 10−6 M.
Journal ArticleDOI
On the inability of tryptamine to serve as a precursor of serotonin.
Sidney Udenfriend,Cyrus R. Creveling,Herbert S. Posner,Betty Redfield,John W. Daly,Bernard Witkop +5 more
TL;DR: Tryptamine when administered to animals neither increases the levels of serotonin in tissues nor the amounts of 5-hydroxyindoleacetic acid in the urine, but when rat liver microsomes were incubated with tryptamine, no serotonin could be detected although phenolic material was formed.